Advertisement
Advertisement
GDTC
CytoMed Therapeutics Limited Ordinary Shares
1.06
USDSponsored
+0.02
+2.40%
Mar 25, 16:00 UTC -4
Closed
Pre-Market
1.07
+0.01
+1.32%
GDTC Earnings Reports
Positive Surprise Ratio
No Data Available for GDTC
0%
Next Report
Date of Next Report
Apr 28, 2026
Estimate for Q4 25 (Revenue/ EPS)
$132.60K
/-$0.04
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/--
CytoMed Therapeutics Limited Ordinary Shares earnings per share and revenue
On --, GDTC reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, 3 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 132.60 thousand USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
BioCardia, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.06
Surprise
+65.40%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
FAQ
What were CytoMed Therapeutics Limited Ordinary Shares's earnings and revenue for the latest quarter Q-- --?
For Q-- --, CytoMed Therapeutics Limited Ordinary Shares reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to CytoMed Therapeutics Limited Ordinary Shares's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is CytoMed Therapeutics Limited Ordinary Shares expected to report next?
The next earning report is scheduled for Apr 28, 2026.
What are the forecasts for CytoMed Therapeutics Limited Ordinary Shares's next earnings report?
Based on 3
analysts, CytoMed Therapeutics Limited Ordinary Shares is expected to report EPS of -$0.04 and revenue of $132.60K for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement